Context
A consortium led by Cinven and Astorg has acquired LGC Group from KKR. The transaction, which represents the first investment for Cinven's seventh fund. KKR, which acquired LGC in 2015 from Bridgepoint, reportedly achieved a 3x return on its investment following 15 bolt-on acquisitions and accelerated organic growth. The strategic rationale for the deal is to capitalize on LGC’s leading positions in the diversified and fast-growing genomics and quality assurance sectors. The new owners intend to back the existing management team, led by CEO Tim Robinson, to further expand LGC’s global presence, particularly in the US and Asia, and to pursue significant future development opportunities through complementary acquisitions. The deal was supported by a substantial new capital structure, including senior secured term loans and a 500 million GBP PIK (Payment-in-Kind) facility.
In the past, the company had already been the subject of several LBOs, notably led by Bridgepoint in 2010 and Kkr in 2015. These multiple LBO cycles illustrate the strong appeal for this type of asset.
LGC GROUP, which reported an EBITDA margin of LOGIN in 2019, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN to the average currently observed in the Business Services sector (11.1x).
Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.
-> Deep-dive in Business Services market trends
Target
LGC Group is a global leader in the Life Science Tools sector, providing critical measurement tools, specialty genomics reagents, and supply chain assurance standards. Established in 1842, the organization serves over 50,000 laboratories worldwide across human healthcare, agri-food, and environmental markets. Its portfolio includes proficiency testing schemes and analytical science capabilities essential for public safety and product regulation. The entity operates a global network across 22 countries and employs more than 3,200 people, including internationally recognized scientific experts. Under its mission "Science for a Safer World," the group enables organizations to develop and commercialize new products while advancing research in genomics and quality assurance.
Ent. Value
LOGIN
Equity Value
LOGIN
Multiples
EV / Revenue
LOGIN
EV / EBITDA
LOGIN
EV / EBIT
LOGIN
Historical Financials (GBP)
Other operations with LGC GROUP
| Date | Acquirer | Target | Country | Sector | Deal Context |
|---|---|---|---|---|---|
| 12/2015 | KKR | LGC GROUP | UNITED KINGDOM | Industrial Services | KKR has signed a definitive agreement to acquire LGC Group from the private equity firm Bridgepoint. This secondary LBO marks a transition for LGC following its ownership by Bridgepoint, which acquired the company in 2010 |
| 02/2010 | BRIDGEPOINT | LGC GROUP | UNITED KINGDOM | Industrial Services | The acquisition of LGC by Bridgepoint marks a highly strategic external growth operation, driven by the private equity firm's investment thesis of supporting companies with strong service-based reputations in fragmented but growing markets |
REFERENCES
Valuation range: EV 3b - 100b GBP
Revenue range: 250M - 500M GBP
EBITDA range: 100M - 200M GBP
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of LGC GROUP by CINVEN / ASTORG are reserved for mynth community members. Register for free to unlock full data.
Authors: verified mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).